January 25, 2021
Seer Announces Proposed Public Offering of Common Stock
January 11, 2021
Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Proteomics
January 11, 2021
Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics
January 4, 2021
Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference
Pagination